BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33315086)

  • 21. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
    McNeil EM; Melton DW
    Nucleic Acids Res; 2012 Nov; 40(20):9990-10004. PubMed ID: 22941649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
    Wang AT; Sengerová B; Cattell E; Inagawa T; Hartley JM; Kiakos K; Burgess-Brown NA; Swift LP; Enzlin JH; Schofield CJ; Gileadi O; Hartley JA; McHugh PJ
    Genes Dev; 2011 Sep; 25(17):1859-70. PubMed ID: 21896658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide excision repair endonuclease genes in Drosophila melanogaster.
    Sekelsky JJ; Hollis KJ; Eimerl AI; Burtis KC; Hawley RS
    Mutat Res; 2000 Apr; 459(3):219-28. PubMed ID: 10812334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.
    Jaspers NG; Raams A; Silengo MC; Wijgers N; Niedernhofer LJ; Robinson AR; Giglia-Mari G; Hoogstraten D; Kleijer WJ; Hoeijmakers JH; Vermeulen W
    Am J Hum Genet; 2007 Mar; 80(3):457-66. PubMed ID: 17273966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair.
    Gaillard PHL; Wood RD
    Nucleic Acids Res; 2001 Feb; 29(4):872-9. PubMed ID: 11160918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruitment and positioning determine the specific role of the XPF-ERCC1 endonuclease in interstrand crosslink repair.
    Klein Douwel D; Hoogenboom WS; Boonen RA; Knipscheer P
    EMBO J; 2017 Jul; 36(14):2034-2046. PubMed ID: 28292785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer.
    Priya Doss CG; Nagasundaram N
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1265-81. PubMed ID: 24158589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice.
    Prasher JM; Lalai AS; Heijmans-Antonissen C; Ploemacher RE; Hoeijmakers JH; Touw IP; Niedernhofer LJ
    EMBO J; 2005 Feb; 24(4):861-71. PubMed ID: 15692571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
    Matoka DJ; Yao V; Harya DS; Gregg JL; Robinson AR; Niedernhofer LJ; Parwani AV; Maier C; Bacich DJ
    Prostate; 2012 Aug; 72(11):1214-22. PubMed ID: 22212909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
    Fisher LA; Samson L; Bessho T
    Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A neurological phenotype in mice with DNA repair gene Ercc1 deficiency.
    Lawrence NJ; Sacco JJ; Brownstein DG; Gillingwater TH; Melton DW
    DNA Repair (Amst); 2008 Feb; 7(2):281-91. PubMed ID: 18221731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Comparison of XPF Missense Mutations Associated to Multiple DNA Repair Disorders.
    Marín M; Ramírez MJ; Carmona MA; Jia N; Ogi T; Bogliolo M; Surrallés J
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30658521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
    Zhang N; Liu X; Li L; Legerski R
    DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA interstrand crosslink repair by XPF-ERCC1 homologue confers ultraviolet resistance in Neurospora crassa.
    Tsukada K; Hatakeyama S; Tanaka S
    Fungal Genet Biol; 2023 Jan; 164():103752. PubMed ID: 36435348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.
    Takahata C; Masuda Y; Takedachi A; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2015 Aug; 36(8):841-51. PubMed ID: 26025908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
    Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
    Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
    Gregg SQ; Robinson AR; Niedernhofer LJ
    DNA Repair (Amst); 2011 Jul; 10(7):781-91. PubMed ID: 21612988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.